The new medical product, launched in December 2025, is a primary driver of new annualized premium sales, indicating a strategic focus on product innovation to capture market share. This creates needs for marketing, sales enablement, and policy administration systems to support the new product's lifecycle.
Filing excerpt
The increase in new annualized premium sales on a Japanese yen basis in the first six months of 2026 was driven primarily by strong sales of Tsumitasu and Anshin Palette.
What this signalsFilings often name leadership changes, deals and spending plans.
Regions named
sec-10qproductLaunchGet every 10-Q signal for Aflac and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Aflac this week?”
The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/f31aa719-f9b1-4ec3-835d-e3da08b5f933 returns this record as JSON. POST /v1/companies/enrich returns every signal for aflac.com.
{
"signal_id": "f31aa719-f9b1-4ec3-835d-e3da08b5f933",
"signal_type": "sec-10q",
"signal_subtype": "productLaunch",
"detected_at": "2026-08-11T08:05:00.406+00:00",
"company": {
"name": "Aflac",
"domain": "aflac.com"
},
"data": {
"detail": "The new medical product, launched in December 2025, is a primary driver of new annualized premium sales, indicating a strategic focus on product innovation to capture market share. This creates needs for marketing, sales enablement, and policy administration systems to support the new product's lifecycle.",
"metrics": {
"timeframe": "current_year"
},
"summary": "Aflac Japan's new medical product 'Anshin Palette' drives H1 2026 sales growth",
"excerpts": "The increase in new annualized premium sales on a Japanese yen basis in the first six months of 2026 was driven primarily by strong sales of Tsumitasu and Anshin Palette.",
"relevance": 0.8,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/4977/000162828026054618/afl-20260630.htm",
"filing_date": "2026-08-07",
"filing_year": 2026,
"fiscal_year": 0,
"fiscal_year_end": "06/30",
"sales_relevance": "Go-to-market support",
"signal_category": "strategic",
"regions_mentioned": [
"Japan"
]
}
}
curl https://signals.autobound.ai/v1/signals/f31aa719-f9b1-4ec3-835d-e3da08b5f933 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"aflac.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.